|
1
|
Wan J and Zhang X, Liu T and Zhang X:
Strategies and developments of immunotherapies in osteosarcoma.
Oncol Lett. 11:511–520. 2016.PubMed/NCBI
|
|
2
|
Endo-Munoz L, Evdokiou A and Saunders NA:
The role of osteoclasts and tumour-associated macrophages in
osteosarcoma metastasis. Biochim Biophys Acta. 1826:434–442.
2012.PubMed/NCBI
|
|
3
|
Lamora A, Talbot J, Bougras G, Amiaud J,
Leduc M, Chesneau J, Taurelle J, Stresing V, Le Deley MC, Heymann
MF, et al: Overexpression of smad7 blocks primary tumor growth and
lung metastasis development in osteosarcoma. Clin Cancer Res.
20:5097–5112. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Poletajew S, Fus L and Wasiutyński A:
Current concepts on pathogenesis and biology of metastatic
osteosarcoma tumors. Ortop Traumatol Rehabil. 13:537–545. 2011.(In
English, Polish). View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang X, Cao W, Lin H, Zhang W, Lin W, Cao
L, Zhen H, Huo J and Zhang X: Isoform-specific expression of 14-3-3
proteins in human astrocytoma. J Neurol Sci. 276:54–59. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Freeman AK and Morrison DK: 14-3-3
Proteins: Diverse functions in cell proliferation and cancer
progression. Semin Cell Dev Biol. 22:681–687. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tzivion G, Gupta VS, Kaplun L and Balan V:
14-3-3 proteins as potential oncogenes. Semin Cancer Biol.
16:203–213. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Niemantsverdriet M, Wagner K, Visser M and
Backendorf C: Cellular functions of 14-3-3 zeta in apoptosis and
cell adhesion emphasize its oncogenic character. Oncogene.
27:1315–1319. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee CH, Ou WB, Mariño-Enriquez A, Zhu M,
Mayeda M, Wang Y, Guo X, Brunner AL, Amant F, French CA, et al:
14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma.
Proc Natl Acad Sci USA. 109:pp. 929–934. 2012; View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qi W, Liu X, Qiao D and Martinez JD:
Isoform-specific expression of 14-3-3 proteins in human lung cancer
tissues. Int J Cancer. 113:359–363. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu Y, Tian RF, Li YM, Liu WP, Cao L, Yang
XL, Cao WD and Zhang X: The expression of seven 14-3-3 isoforms in
human meningioma. Brain Res. 1336:98–102. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wilker EW, van Vugt MA, Artim SA, Huang
PH, Petersen CP, Reinhardt HC, Feng Y, Sharp PA, Sonenberg N, White
FM and Yaffe MB: 14-3-3sigma controls mitotic translation to
facilitate cytokinesis. Nature. 446:329–332. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun N, Wu Y, Huang B, Liu Q, Dong Y, Ding
J and Liu Y: Decreased expression of 14-3-3 σ, an early event of
malignant transformation of respiratory epithelium, also
facilitates progression of squamous cell lung cancer. Thorac
Cancer. 6:715–721. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Radhakrishnan VM, Putnam CW, Qi W and
Martinez JD: P53 suppresses expression of the 14-3-3 gamma
oncogene. BMC Cancer. 11:3782011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mulvey HE, Chang A, Adler J, Del Tatto M,
Perez K, Quesenberry PJ and Chatterjee D: Extracellular
vesicle-mediated phenotype switching in malignant and non-malignant
colon cells. BMC Cancer. 15:5712015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li N, Wang H, Fan J, Tong C, Yang J, Wei
H, Yi J and Ling R: Overexpression of 14-3-3θ promotes tumor
metastasis and indicates poor prognosis in breast carcinoma.
Oncotarget. 5:249–257. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu TA, Jan YJ, Ko BS, Chen SC, Liang SM,
Hung YL, Hsu C, Shen TL, Lee YM, Chen PF, et al: Increased
expression of 14-3-3β promotes tumor progression and predicts
extrahepatic metastasis and worse survival in hepatocellular
carcinoma. Am J Pathol. 179:2698–2708. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tang Y, Lv P, Sun Z, Han L and Zhou W:
14-3-3β promotes migration and invasion of human hepatocellular
carcinoma cells by modulating expression of MMP2 and MMP9 through
PI3K/Akt/NF-κB pathway. PLoS One. 11:e01460702016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gong F, Wang G, Ye J, Li T, Bai H and Wang
W: 14-3-3β regulates the proliferation of glioma cells through the
GSK3β/β-catenin signaling pathway. Oncol Rep. 30:2976–2982. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Takihara Y, Matsuda Y and Hara J: Role of
the beta isoform of 14-3-3 proteins in cellular proliferation and
oncogenic transformation. Carcinogenesis. 21:2073–2077. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang Z, Nesland JM, Suo Z, Trope CG and
Holm R: The prognostic value of 14-3-3 isoforms in vulvar squamous
cell carcinoma cases: 14-3-3β and ε are independent prognostic
factors for these tumors. PLoS One. 6:e248432011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhu J, Liu F, Wu Q and Liu X: Activin A
regulates proliferation, invasion and migration in osteosarcoma
cells. Mol Med Rep. 11:4501–4507. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim JO, Kim SR, Lim KH, Kim JH, Ajjappala
B, Lee HJ, Choi JI and Baek KH: Deubiquitinating enzyme USP37
regulating oncogenic function of 14-3-3γ. Oncotarget.
6:36551–36576. 2015.PubMed/NCBI
|
|
25
|
Wu YJ, Jan YJ, Ko BS, Liang SM and Liou
JY: Involvement of 14-3-3 proteins in regulating tumor progression
of hepatocellular carcinoma. Cancers (Basel). 7:1022–1036. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cheng AS, Lau SS, Chen Y, Kondo Y, Li MS,
Feng H, Ching AK, Cheung KF, Wong HK, Tong JH, et al: EZH2-mediated
concordant repression of Wnt antagonists promotes
β-catenin-dependent hepatocarcinogenesis. Cancer Res. 71:4028–4039.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Stewart DJ: Wnt signaling pathway in
non-small cell lung cancer. J Natl Cancer Inst. 106:djt3562014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cao L, Lei H, Chang MZ, Liu ZQ and Bie XH:
Down-regulation of 14-3-3β exerts anti-cancer effects through
inducing ER stress in human glioma U87 cells: Involvement of
CHOP-Wnt pathway. Biochem Biophys Res Commun. 462:389–395. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen H, Liu L, Ma B, Ma TM, Hou JJ, Xie
GM, Wu W, Yang FQ and Chen YG: Protein kinase A-mediated 14-3-3
association impedes human Dapper1 to promote dishevelled
degradation. J Biol Chem. 286:14870–14880. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ma Y, Li YF, Wang T, Pang R, Xue YW and
Zhao SP: Identification of proteins associated with lymph node
metastasis of gastric cancer. J Cancer Res Clin Oncol.
140:1739–1749. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Okayama A, Miyagi Y, Oshita F, Nishi M,
Nakamura Y, Nagashima Y, Akimoto K, Ryo A and Hirano H: Proteomic
analysis of proteins related to prognosis of lung adenocarcinoma. J
Proteome Res. 13:4686–4694. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cai J, Feng D, Hu L, Chen H, Yang G, Cai
Q, Gao C and Wei D: FAT4 functions as a tumour suppressor in
gastric cancer by modulating Wnt/β-catenin signalling. Br J Cancer.
113:1720–1729. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ye GD, Sun GB, Jiao P, Chen C, Liu QF,
Huang XL, Zhang R, Cai WY, Li SN and Wu JF: OVOL2, an inhibitor of
WNT signaling, reduces invasive activities of human and mouse
cancer cells and is down-regulated in human colorectal tumors.
Gastroenterology. 150:659–671.e16. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fan Y and Guo Y: Knockdown of eIF3D
inhibits breast cancer cell proliferation and invasion through
suppressing the Wnt/β-catenin signaling pathway. Int J Clin Exp
Pathol. 8:10420–10427. 2015.PubMed/NCBI
|
|
35
|
Deng Z, Wang L, Hou H, Zhou J and Li X:
Epigenetic regulation of IQGAP2 promotes ovarian cancer progression
via activating Wnt/β-catenin signaling. Int J Oncol. 48:153–160.
2015.PubMed/NCBI
|
